These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 35965101)

  • 1. The emerging roles of CFIm25 (NUDT21/CPSF5) in human biology and disease.
    Masamha CP
    Wiley Interdiscip Rev RNA; 2023; 14(3):e1757. PubMed ID: 35965101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CFIm25 and alternative polyadenylation: Conflicting roles in cancer.
    Jafari Najaf Abadi MH; Shafabakhsh R; Asemi Z; Mirzaei HR; Sahebnasagh R; Mirzaei H; Hamblin MR
    Cancer Lett; 2019 Sep; 459():112-121. PubMed ID: 31181319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nudt21 regulates the alternative polyadenylation of Pak1 and is predictive in the prognosis of glioblastoma patients.
    Chu Y; Elrod N; Wang C; Li L; Chen T; Routh A; Xia Z; Li W; Wagner EJ; Ji P
    Oncogene; 2019 May; 38(21):4154-4168. PubMed ID: 30705404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of cleavage factor Im 25 promotes the proliferation of lung cancer cells through alternative polyadenylation.
    Huang J; Weng T; Ko J; Chen NY; Xiang Y; Volcik K; Han L; Blackburn MR; Lu X
    Biochem Biophys Res Commun; 2018 Sep; 503(2):856-862. PubMed ID: 29928883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between NUDT21 mediated alternative polyadenylation process and tumor.
    Xiao S; Gu H; Deng L; Yang X; Qiao D; Zhang X; Zhang T; Yu T
    Front Oncol; 2023; 13():1052012. PubMed ID: 36816917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CFIm25 links alternative polyadenylation to glioblastoma tumour suppression.
    Masamha CP; Xia Z; Yang J; Albrecht TR; Li M; Shyu AB; Li W; Wagner EJ
    Nature; 2014 Jun; 510(7505):412-6. PubMed ID: 24814343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Cancer-Specific Ubiquitin Ligase Drives mRNA Alternative Polyadenylation by Ubiquitinating the mRNA 3' End Processing Complex.
    Yang SW; Li L; Connelly JP; Porter SN; Kodali K; Gan H; Park JM; Tacer KF; Tillman H; Peng J; Pruett-Miller SM; Li W; Potts PR
    Mol Cell; 2020 Mar; 77(6):1206-1221.e7. PubMed ID: 31980388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NUDT21 negatively regulates PSMB2 and CXXC5 by alternative polyadenylation and contributes to hepatocellular carcinoma suppression.
    Tan S; Li H; Zhang W; Shao Y; Liu Y; Guan H; Wu J; Kang Y; Zhao J; Yu Q; Gu Y; Ding K; Zhang M; Qian W; Zhu Y; Cai H; Chen C; Lobie PE; Zhao X; Sun J; Zhu T
    Oncogene; 2018 Aug; 37(35):4887-4900. PubMed ID: 29780166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor β1 alters the 3'-UTR of mRNA to promote lung fibrosis.
    Ko J; Mills T; Huang J; Chen NY; Mertens TCJ; Collum SD; Lee G; Xiang Y; Han L; Zhou Y; Lee CG; Elias JA; Jyothula SSK; Rajagopal K; Karmouty-Quintana H; Blackburn MR
    J Biol Chem; 2019 Oct; 294(43):15781-15794. PubMed ID: 31488543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partial loss of CFIm25 causes learning deficits and aberrant neuronal alternative polyadenylation.
    Alcott CE; Yalamanchili HK; Ji P; van der Heijden ME; Saltzman A; Elrod N; Lin A; Leng M; Bhatt B; Hao S; Wang Q; Saliba A; Tang J; Malovannaya A; Wagner EJ; Liu Z; Zoghbi HY
    Elife; 2020 Apr; 9():. PubMed ID: 32319885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of CFIm25 amplifies dermal fibrosis through alternative polyadenylation.
    Weng T; Huang J; Wagner EJ; Ko J; Wu M; Wareing NE; Xiang Y; Chen NY; Ji P; Molina JG; Volcik KA; Han L; Mayes MD; Blackburn MR; Assassi S
    J Exp Med; 2020 Feb; 217(2):. PubMed ID: 31757866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NUDT21 regulates circRNA cyclization and ceRNA crosstalk in hepatocellular carcinoma.
    Li X; Ding J; Wang X; Cheng Z; Zhu Q
    Oncogene; 2020 Jan; 39(4):891-904. PubMed ID: 31570791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CFIm-mediated alternative polyadenylation safeguards the development of mammalian pre-implantation embryos.
    Li N; Cai Y; Zou M; Zhou J; Zhang L; Zhou L; Xiang W; Cui Y; Li H
    Stem Cell Reports; 2023 Jan; 18(1):81-96. PubMed ID: 36563685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CFIm-mediated alternative polyadenylation remodels cellular signaling and miRNA biogenesis.
    Ghosh S; Ataman M; Bak M; Börsch A; Schmidt A; Buczak K; Martin G; Dimitriades B; Herrmann CJ; Kanitz A; Zavolan M
    Nucleic Acids Res; 2022 Apr; 50(6):3096-3114. PubMed ID: 35234914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA Binding Protein CELF2 Regulates Signal-Induced Alternative Polyadenylation by Competing with Enhancers of the Polyadenylation Machinery.
    Chatrikhi R; Mallory MJ; Gazzara MR; Agosto LM; Zhu WS; Litterman AJ; Ansel KM; Lynch KW
    Cell Rep; 2019 Sep; 28(11):2795-2806.e3. PubMed ID: 31509743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implications of polyadenylation in health and disease.
    Curinha A; Oliveira Braz S; Pereira-Castro I; Cruz A; Moreira A
    Nucleus; 2014; 5(6):508-19. PubMed ID: 25484187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NUDT21 regulates 3'-UTR length and microRNA-mediated gene silencing in hepatocellular carcinoma.
    Sun M; Ding J; Li D; Yang G; Cheng Z; Zhu Q
    Cancer Lett; 2017 Dec; 410():158-168. PubMed ID: 28964783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cleavage factor 25 deregulation contributes to pulmonary fibrosis through alternative polyadenylation.
    Weng T; Ko J; Masamha CP; Xia Z; Xiang Y; Chen NY; Molina JG; Collum S; Mertens TC; Luo F; Philip K; Davies J; Huang J; Wilson C; Thandavarayan RA; Bruckner BA; Jyothula SS; Volcik KA; Li L; Han L; Li W; Assassi S; Karmouty-Quintana H; Wagner EJ; Blackburn MR
    J Clin Invest; 2019 May; 129(5):1984-1999. PubMed ID: 30830875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NUDT21 inhibits bladder cancer progression through ANXA2 and LIMK2 by alternative polyadenylation.
    Xiong M; Chen L; Zhou L; Ding Y; Kazobinka G; Chen Z; Hou T
    Theranostics; 2019; 9(24):7156-7167. PubMed ID: 31695759
    [No Abstract]   [Full Text] [Related]  

  • 20. LINC00921 reduces lung cancer radiosensitivity by destabilizing NUDT21 and driving aberrant MED23 alternative polyadenylation.
    Zhang N; Liu X; Huang L; Zeng J; Ma C; Han L; Li W; Yu J; Yang M
    Cell Rep; 2023 Dec; 42(12):113479. PubMed ID: 37999979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.